keyword
https://read.qxmd.com/read/38615588/generation-of-two-induced-pluripotent-stem-cell-lines-lvpeii007-b-lvpeii008-b-from-patients-harboring-homozygous-mutation-in-abca4-c-6088c-t-using-non-integrative-sendai-virus-based-approach
#1
JOURNAL ARTICLE
Divya Pidishetty, Savitri Maddileti, Sudipta Mahato, Trupti Agrawal, Vinay Kumar Pulimamidi, Milind Naik, Chitra Kannabiran, Subhadra Jalali, Indumathi Mariappan
Mutations in ABCA4 gene leads to the most common form of an inherited retinal disease namely, the Stargardt disease, type 1. Here, we report the generation of two different patient-specific induced pluripotent stem cell lines (LVPEIi007-B and LVPEIi008-B), carrying an identical homozygous mutation, (c.6088C>T) within the exon 44 of ABCA4 gene. These lines were generated by the reprogramming of patient-specific dermal fibroblasts, using the integration-free, Sendai viral vectors. Both lines were stably expanded and expressed the stemness and pluripotency markers, differentiated into cell types of all three germ layers, and maintained a normal karyotype...
April 9, 2024: Stem Cell Research
https://read.qxmd.com/read/38607040/preclinical-development-of-antisense-oligonucleotides-to-rescue-aberrant-splicing-caused-by-an-ultrarare-abca4-variant-in-a-child-with-early-onset-stargardt-disease
#2
JOURNAL ARTICLE
Nuria Suárez-Herrera, Catherina H Z Li, Nico Leijsten, Dyah W Karjosukarso, Zelia Corradi, Femke Bukkems, Lonneke Duijkers, Frans P M Cremers, Carel B Hoyng, Alejandro Garanto, Rob W J Collin
Precision medicine is rapidly gaining recognition in the field of (ultra)rare conditions, where only a few individuals in the world are affected. Clinical trial design for a small number of patients is extremely challenging, and for this reason, the development of N-of-1 strategies is explored to accelerate customized therapy design for rare cases. A strong candidate for this approach is Stargardt disease (STGD1), an autosomal recessive macular degeneration characterized by high genetic and phenotypic heterogeneity...
March 29, 2024: Cells
https://read.qxmd.com/read/38602673/representation-of-women-among-individuals-with-mild-variants-in-abca4-associated-retinopathy-a-meta-analysis
#3
JOURNAL ARTICLE
Stéphanie S Cornelis, Joanna IntHout, Esmee H Runhart, Olivier Grunewald, Siying Lin, Zelia Corradi, Mubeen Khan, Rebekkah J Hitti-Malin, Laura Whelan, G Jane Farrar, Dror Sharon, L Ingeborgh van den Born, Gavin Arno, Mark Simcoe, Michel Michaelides, Andrew R Webster, Susanne Roosing, Omar A Mahroo, Claire-Marie Dhaenens, Frans P M Cremers
IMPORTANCE: Previous studies indicated that female sex might be a modifier in Stargardt disease, which is an ABCA4-associated retinopathy. OBJECTIVE: To investigate whether women are overrepresented among individuals with ABCA4-associated retinopathy who are carrying at least 1 mild allele or carrying nonmild alleles. DATA SOURCES: Literature data, data from 2 European centers, and a new study. Data from a Radboudumc database and from the Rotterdam Eye Hospital were used for exploratory hypothesis testing...
April 11, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38585957/quantification-of-fundus-autofluorescence-features-in-a-molecularly-characterized-cohort-of-more-than-3000-inherited-retinal-disease-patients-from-the-united-kingdom
#4
William Woof, Thales A C de Guimarães, Saoud Al-Khuzaei, Malena Daich Varela, Sagnik Sen, Pallavi Bagga, Bernardo Mendes, Mital Shah, Paula Burke, David Parry, Siying Lin, Gunjan Naik, Biraja Ghoshal, Bart Liefers, Dun Jack Fu, Michalis Georgiou, Quang Nguyen, Alan Sousa da Silva, Yichen Liu, Yu Fujinami-Yokokawa, Nathaniel Kabiri, Dayyanah Sumodhee, Praveen Patel, Jennifer Furman, Ismail Moghul, Juliana Sallum, Samantha R De Silva, Birgit Lorenz, Frank Holz, Kaoru Fujinami, Andrew R Webster, Omar Mahroo, Susan M Downes, Savita Madhusuhan, Konstantinos Balaskas, Michel Michaelides, Nikolas Pontikos
PURPOSE: To quantify relevant fundus autofluorescence (FAF) image features cross-sectionally and longitudinally in a large cohort of inherited retinal diseases (IRDs) patients. DESIGN: Retrospective study of imaging data (55-degree blue-FAF on Heidelberg Spectralis) from patients. PARTICIPANTS: Patients with a clinical and molecularly confirmed diagnosis of IRD who have undergone FAF 55-degree imaging at Moorfields Eye Hospital (MEH) and the Royal Liverpool Hospital (RLH) between 2004 and 2019...
March 28, 2024: medRxiv
https://read.qxmd.com/read/38576124/beyond-the-phenotype-exploring-inherited-retinal-diseases-with-targeted-next-generation-sequencing-in-a-turkish-cohort
#5
JOURNAL ARTICLE
Busra Ozguc Caliskan, Kubra Uslu, Neslihan Sinim Kahraman, Kuddusi Erkilic, Ayse Oner, Munis Dundar
This research aims to compile recent clinical and genetic data from Turkish patients with inherited retinal disorders and evaluate the effectiveness of targeted Next-generation sequencing panels. The study included Turkish individuals with hereditary retinal diseases who visited the Medical Genetic Department of Erciyes University between 2019 and 2022. One proband per family was selected based on eligibility. We used Hereditary Disorder Solution (HDS) by Sophia Genetics and performed next-generation sequencing (NGS) with Illumina NextSeq-500...
April 4, 2024: Clinical Genetics
https://read.qxmd.com/read/38560110/abca4-mediated-traumatic-proliferative-vitreoretinopathy-associated-with-pi3k-akt-signaling-pathway
#6
JOURNAL ARTICLE
Wang Menghua, Zhirou Hu
BACKGROUND: Proliferative vitreoretinopathy (PVR) is the main cause of retinal detachment. However, the underlying mechanism of PVR is complex and has not yet been fully elucidated. The PI3K/Akt/mTOR signaling pathway is involved in angiogenesis and plays an important role in cell proliferation and tumor formation. Therefore, our study was designed to investigate the potential biological mechanisms of alleviating ARPE-19 cell and traumatic PVR model involving PI3K/Akt signaling pathway by targeting ABCA4...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38540785/towards-uncovering-the-role-of-incomplete-penetrance-in-maculopathies-through-sequencing-of-105-disease-associated-genes
#7
JOURNAL ARTICLE
Rebekkah J Hitti-Malin, Daan M Panneman, Zelia Corradi, Erica G M Boonen, Galuh Astuti, Claire-Marie Dhaenens, Heidi Stöhr, Bernhard H F Weber, Dror Sharon, Eyal Banin, Marianthi Karali, Sandro Banfi, Tamar Ben-Yosef, Damjan Glavač, G Jane Farrar, Carmen Ayuso, Petra Liskova, Lubica Dudakova, Marie Vajter, Monika Ołdak, Jacek P Szaflik, Anna Matynia, Michael B Gorin, Kati Kämpjärvi, Miriam Bauwens, Elfride De Baere, Carel B Hoyng, Catherina H Z Li, Caroline C W Klaver, Chris F Inglehearn, Kaoru Fujinami, Carlo Rivolta, Rando Allikmets, Jana Zernant, Winston Lee, Osvaldo L Podhajcer, Ana Fakin, Jana Sajovic, Alaa AlTalbishi, Sandra Valeina, Gita Taurina, Andrea L Vincent, Lisa Roberts, Raj Ramesar, Giovanna Sartor, Elena Luppi, Susan M Downes, L Ingeborgh van den Born, Terri L McLaren, John N De Roach, Tina M Lamey, Jennifer A Thompson, Fred K Chen, Anna M Tracewska, Smaragda Kamakari, Juliana Maria Ferraz Sallum, Hanno J Bolz, Hülya Kayserili, Susanne Roosing, Frans P M Cremers
Inherited macular dystrophies (iMDs) are a group of genetic disorders, which affect the central region of the retina. To investigate the genetic basis of iMDs, we used single-molecule Molecular Inversion Probes to sequence 105 maculopathy-associated genes in 1352 patients diagnosed with iMDs. Within this cohort, 39.8% of patients were considered genetically explained by 460 different variants in 49 distinct genes of which 73 were novel variants, with some affecting splicing. The top five most frequent causative genes were ABCA4 (37...
March 19, 2024: Biomolecules
https://read.qxmd.com/read/38499139/genetic-and-clinical-features-of-abca4-associated-retinopathy-in-a-japanese-nationwide-cohort
#8
JOURNAL ARTICLE
Kei Mizobuchi, Takaaki Hayashi, Koji Tanaka, Kazuki Kuniyoshi, Yusuke Murakami, Natsuko Nakamura, Kaoruko Torii, Atsushi Mizota, Daiki Sakai, Akiko Maeda, Taro Kominami, Shinji Ueno, Shunji Kusaka, Koji M Nishiguchi, Yasuhiro Ikeda, Mineo Kondo, Kazushige Tsunoda, Yoshihiro Hotta, Tadashi Nakano
PURPOSE: To clarify the genetic and clinical features of Japanese patients with ABCA4-associated retinopathy. DESIGN: Retrospective, multicenter cohort study METHODS: Patients with retinal degeneration and biallelic ABCA4 variants were recruited from 13 different hospitals. Whole exome sequencing analysis was used for genetic testing. Comprehensive ophthalmic examinations were performed on matched patients. The primary outcome measure was identifying multimodal retinal imaging findings associated with disease progression...
March 16, 2024: American Journal of Ophthalmology
https://read.qxmd.com/read/38466963/understanding-and-rescuing-the-splicing-defect-caused-by-the-frequent-abca4-variant-c-4253-43g-a-underlying-stargardt-disease
#9
JOURNAL ARTICLE
Nuria Suárez-Herrera, Alejandro Garanto, Rob W J Collin
Pathogenic variants in ABCA4 are the underlying molecular cause of Stargardt disease (STGD1), an autosomal recessive macular dystrophy characterized by a progressive loss of central vision. Among intronic ABCA4 variants, c.4253+43G>A is frequently detected in STGD1 cases and is classified as a hypomorphic allele, generally associated with late-onset cases. This variant was previously reported to alter splicing regulatory sequences, but the splicing outcome is not fully understood yet. In this study, we attempted to better understand its effect on splicing and to rescue the aberrant splicing via antisense oligonucleotides (AONs)...
March 12, 2024: Nucleic Acid Therapeutics
https://read.qxmd.com/read/38443629/intravitreal-delivery-of-pegylated-eco-plasmid-dna-nanoparticles-for-gene-therapy-of-stargardt-disease
#10
JOURNAL ARTICLE
Da Sun, Wenyu Sun, Song-Qi Gao, Jonathan Lehrer, Hong Wang, Ryan Hall, Zheng-Rong Lu
OBJECTIVE: Current gene therapy of inherited retinal diseases is achieved mainly by subretinal injection, which is invasive with severe adverse effects. Intravitreal injection is a minimally invasive alternative for gene therapy of inherited retinal diseases. This work explores the efficacy of intravitreal delivery of PEGylated ECO (a multifunctional pH-sensitive amphiphilic amino lipid) plasmid DNA (pGRK1-ABCA4-S/MAR) nanoparticles (PEG-ELNP) for gene therapy of Stargardt disease. METHODS: Pigmented Abca4-/- knockout mice received 1 µL of PEG-ELNP solution (200 ng/uL, pDNA concentration) by intravitreal injections at an interval of 1...
March 5, 2024: Pharmaceutical Research
https://read.qxmd.com/read/38369462/-abca4-variant-screening-in-a-turkish-cohort-with-stargardt-disease
#11
JOURNAL ARTICLE
Neslihan Sinim Kahraman, Büşra Özgüç Çalışkan, Nefise Kandemir, Ayşe Öner, Munis Dündar, Yusuf Özkul
PURPOSE: This study aims to evaluate the ABCA4 variants in patients diagnosed with Stargardt disease. METHODS: This is a retrospective study designed to investigate variants in the ABCA4 in Stargardt disease and the clinical findings of the cases. Sex, age, age of onset of symptoms, best-corrected visual acuity, color fundus photography, optical coherence tomography, and visual field test of the patients were recorded. Genetic analyses were screened, and patients with at least two variants in the ABCA4 were included in this study...
February 18, 2024: Ophthalmic Genetics
https://read.qxmd.com/read/38347443/spectrum-of-variants-associated-with-inherited-retinal-dystrophies-in-northeast-mexico
#12
JOURNAL ARTICLE
Rocio A Villafuerte-de la Cruz, Lucas A Garza-Garza, Manuel Garza-Leon, Cesar Rodriguez-De la Torre, Cinthya Parra-Bernal, Ilse Vazquez-Camas, David Ramos-Gonzalez, Andrea Rangel-Padilla, Angelina Espino Barros-Palau, Jose Nava-García, Javier Castillo-Velazquez, Erick Castillo-De Leon, Agustin Del Valle-Penella, Jorge E Valdez-Garcia, Augusto Rojas-Martinez
BACKGROUND: Inherited retinal dystrophies are hereditary diseases which have in common the progressive degeneration of photoreceptors. They are a group of diseases with clinical, genetic, and allelic heterogeneity. There is limited information regarding the genetic landscape of inherited retinal diseases in Mexico, therefore, the present study was conducted in the northeast region of the country. METHODS: Patients with inherited retinal dystrophies were included...
February 12, 2024: BMC Ophthalmology
https://read.qxmd.com/read/38309476/a-retrospective-longitudinal-study-of-460-patients-with-abca4-associated-retinal-disease
#13
JOURNAL ARTICLE
Beau J Fenner, S Scott Whitmore, Adam P DeLuca, Jean L Andorf, Heather T Daggett, Meagan A Luse, Lorena M Haefeli, Janet B Riley, Douglas B Critser, Mark E Wilkinson, Alina V Dumitrescu, Arlene V Drack, Timothy M Boyce, Jonathan F Russell, Elaine M Binkley, Elliott H Sohn, Stephen R Russell, Culver H Boldt, Robert F Mullins, Budd A Tucker, Todd E Scheetz, Ian C Han, Edwin M Stone
PURPOSE: To investigate the distribution of genotypes and natural history of ABCA4-associated retinal disease in a large cohort of patients seen at a single institution. DESIGN: Retrospective, single institution, cohort review. SUBJECTS: Patients seen at the University of Iowa between November 1986 and August 2022 clinically suspected to have disease caused by sequence variations in ABCA4. METHODS: DNA samples from participants were subjected to a tiered testing strategy progressing from allele-specific screening to whole genome sequencing...
February 1, 2024: Ophthalmology
https://read.qxmd.com/read/38278208/phenotyping-and-genotyping-inherited-retinal-diseases-molecular-genetics-clinical-and-imaging-features-and-therapeutics-of-macular-dystrophies-cone-and-cone-rod-dystrophies-rod-cone-dystrophies-leber-congenital-amaurosis-and-cone-dysfunction-syndromes
#14
REVIEW
Michalis Georgiou, Anthony G Robson, Kaoru Fujinami, Thales A C de Guimarães, Yu Fujinami-Yokokawa, Malena Daich Varela, Nikolas Pontikos, Angelos Kalitzeos, Omar A Mahroo, Andrew R Webster, Michel Michaelides
Inherited retinal diseases (IRD) are a leading cause of blindness in the working age population and children. The scope of this review is to familiarise clinicians and scientists with the current landscape of molecular genetics, clinical phenotype, retinal imaging and therapeutic prospects/completed trials in IRD. Herein we present in a comprehensive and concise manner: (i) macular dystrophies (Stargardt disease (ABCA4), X-linked retinoschisis (RS1), Best disease (BEST1), PRPH2-associated pattern dystrophy, Sorsby fundus dystrophy (TIMP3), and autosomal dominant drusen (EFEMP1)), (ii) cone and cone-rod dystrophies (GUCA1A, PRPH2, ABCA4, KCNV2 and RPGR), (iii) predominant rod or rod-cone dystrophies (retinitis pigmentosa, enhanced S-Cone syndrome (NR2E3), Bietti crystalline corneoretinal dystrophy (CYP4V2)), (iv) Leber congenital amaurosis/early-onset severe retinal dystrophy (GUCY2D, CEP290, CRB1, RDH12, RPE65, TULP1, AIPL1 and NMNAT1), (v) cone dysfunction syndromes (achromatopsia (CNGA3, CNGB3, PDE6C, PDE6H, GNAT2, ATF6), X-linked cone dysfunction with myopia and dichromacy (Bornholm Eye disease; OPN1LW/OPN1MW array), oligocone trichromacy, and blue-cone monochromatism (OPN1LW/OPN1MW array)...
January 24, 2024: Progress in Retinal and Eye Research
https://read.qxmd.com/read/38274366/splicing-defects-and-crispr-cas9-correction-in-isogenic-homozygous-photoreceptor-precursors-harboring-clustered-deep-intronic-abca4-variants
#15
JOURNAL ARTICLE
Pietro De Angeli, Arturo Flores-Tufiño, Katarina Stingl, Laura Kühlewein, Eleonora Roschi, Bernd Wissinger, Susanne Kohl
Splicing defects from deep-intronic variants significantly contribute to the mutational spectrum in ABCA4 -associated inherited retinal diseases, necessitating functional validation for their pathological classification. Typically, minigene assays in HEK293(T) can qualitatively assess splicing defects, yet they often fail to quantitatively reproduce the resulting mis-splicing patterns, leaving uncertainty on severity and pathogenicity. As a potential cellular model derived from patient cells, photoreceptor precursor cells (PPCs) play a pivotal role in assessing the severity of specific splicing mutations...
March 12, 2024: Molecular Therapy. Nucleic Acids
https://read.qxmd.com/read/38243599/proof-of-concept-for-multiple-aon-delivery-by-a-single-u7snrna-vector-to-restore-splicing-defects-in-abca4
#16
JOURNAL ARTICLE
Nuria Suárez-Herrera, Iris B Riswick, Irene Vázquez-Domínguez, Lonneke Duijkers, Dyah W Karjosukarso, Davide Piccolo, Miriam Bauwens, Elfride De Baere, Michael E Cheetham, Alejandro Garanto, Rob W J Collin
The high allelic heterogeneity in Stargardt Disease (STGD1) complicates the design of intervention strategies. A significant proportion of pathogenic intronic ABCA4 variants alters the pre-mRNA splicing process. Antisense oligonucleotides (AONs) are an attractive yet mutation-specific therapeutic strategy to restore these splicing defects. In this study, we experimentally assessed the potential of a splicing modulation therapy to target multiple intronic ABCA4 variants. Firstly, AONs were inserted into U7snRNA gene cassettes and tested in midigene-based splice assays...
January 18, 2024: Molecular Therapy
https://read.qxmd.com/read/38219857/spectrum-of-genetic-variants-in-the-commonest-genes-causing-inherited-retinal-disease-in-a-large-molecularly-characterised-uk-cohort
#17
JOURNAL ARTICLE
Siying Lin, Sandra Vermeirsch, Nikolas Pontikos, M Pilar Martin-Gutierrez, Malena Daich Varela, Samantha Malka, Elena Schiff, Hannah Knight, Genevieve Wright, Neringa Jurkute, Mark J Simcoe, Patrick Yu-Wai-Man, Mariya Moosajee, Michel Michaelides, Omar A Mahroo, Andrew R Webster, Gavin Arno
PURPOSE: Inherited retinal disease (IRD) is a leading cause of blindness. Recent advances in gene-directed therapies highlight the importance of understanding the genetic basis of these disorders. This study details the molecular spectrum in a large UK IRD patient cohort. DESIGN: Retrospective study of electronic patient records. PARTICIPANTS: Patients with IRD who have attended the Genetics Service at Moorfields Eye Hospital between 2003 and July 2020, in whom a molecular diagnosis has been identified...
January 12, 2024: Ophthalmology Retina
https://read.qxmd.com/read/38195571/highly-efficient-capture-approach-for-the-identification-of-diverse-inherited-retinal-disorders
#18
JOURNAL ARTICLE
Hsiao-Jung Kao, Ting-Yi Lin, Feng-Jen Hsieh, Jia-Ying Chien, Erh-Chan Yeh, Wan-Jia Lin, Yi-Hua Chen, Kai-Hsuan Ding, Yu Yang, Sheng-Chu Chi, Ping-Hsing Tsai, Chih-Chien Hsu, De-Kuang Hwang, Hsien-Yang Tsai, Mei-Ling Peng, Shi-Huang Lee, Siu-Fung Chau, Chen Yu Chen, Wai-Man Cheang, Shih-Jen Chen, Pui-Yan Kwok, Shih-Hwa Chiou, Mei-Yeh Jade Lu, Shun-Ping Huang
Our study presents a 319-gene panel targeting inherited retinal dystrophy (IRD) genes. Through a multi-center retrospective cohort study, we validated the assay's effectiveness and clinical utility and characterized the mutation spectrum of Taiwanese IRD patients. Between January 2018 and May 2022, 493 patients in 425 unrelated families, all initially suspected of having IRD without prior genetic diagnoses, underwent detailed ophthalmic and physical examinations (with extra-ocular features recorded) and genetic testing with our customized panel...
January 9, 2024: NPJ Genomic Medicine
https://read.qxmd.com/read/38182646/qr-1011-restores-defective-abca4-splicing-caused-by-multiple-severe-abca4-variants-underlying-stargardt-disease
#19
JOURNAL ARTICLE
Melita Kaltak, Petra de Bruijn, Willemijn van Leeuwen, Gerard Platenburg, Frans P M Cremers, Rob W J Collin, Jim Swildens
Stargardt disease type 1 (STGD1), the most common form of hereditary macular dystrophy, can be caused by biallelic combinations of over 2200 variants in the ABCA4 gene. This leads to reduced or absent ABCA4 protein activity, resulting in toxic metabolite accumulation in the retina and damage of the retinal pigment epithelium and photoreceptors. Approximately 21% of all ABCA4 variants that contribute to disease influence ABCA4 pre-mRNA splicing. This emphasizes the need for therapies to restore disrupted ABCA4 splicing and halt STGD1 progression...
January 6, 2024: Scientific Reports
https://read.qxmd.com/read/38168987/an-adenine-base-editor-variant-expands-context-compatibility
#20
JOURNAL ARTICLE
Yu-Lan Xiao, Yuan Wu, Weixin Tang
Adenine base editors (ABEs) are precise gene-editing agents that convert A:T pairs into G:C through a deoxyinosine intermediate. Existing ABEs function most effectively when the target A is in a TA context. Here we evolve the Escherichia coli transfer RNA-specific adenosine deaminase (TadA) to generate TadA8r, which extends potent deoxyadenosine deamination to RA (R = A or G) and is faster in processing GA than TadA8.20 and TadA8e, the two most active TadA variants reported so far. ABE8r, comprising TadA8r and a Streptococcus pyogenes Cas9 nickase, expands the editing window at the protospacer adjacent motif-distal end and outperforms ABE7...
January 2, 2024: Nature Biotechnology
keyword
keyword
112493
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.